David A. Gorelick - Concepedia

Author

David A. Gorelick

Also Known As

D A Gorelick, D Gorelick, D. A. GORELICK, D. A. Gorelick, D. Gorelick, D.A Gorelick, D.A. GoreLick, D.A. Gorelick, DAVID A GORELICK, DAVID A. GORELICK

285

Publications

12.6K

Citations

H-Index

120

Concepts

All Affiliations

National Institute on Drug Abuse National Institutes of Health University of Maryland, Baltimore Johns Hopkins University University of California, Los Angeles

About

David A. Gorelick is an author at National Institute on Drug Abuse specializing in medicine, addiction, and substance abuse.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	80	4.2K
2	Health Sciences	30	45	2.9K
3	Social Sciences	16	23	909
4	Public Health	4	4	253
5	African American Studies	1	1	33

David A. Gorelick

148

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716 Marilyn A. Huestis, David A. Gorelick, Stephen J. Heishman, Archives of General Psychiatry	2001	480
Increased mu opioid receptor binding detected by PET in cocaine–dependent men is associated with cocaine craving Jon-Kar Zubieta, David A. Gorelick, Robin Stauffer, Nature Medicine Substance AbuseSubstance UseCocaine CravingPsychiatryBehavioral Neuroscience	1996	274
Cannabis effects on driving lateral control with and without alcohol Rebecca L. Hartman, Timothy L. Brown, Gary Milavetz, Drug and Alcohol Dependence Cannabis UseSubstance AbuseSubstance UseHealth SciencesAddiction	2015	241
Reliability and validity of a short form of the Marijuana Craving Questionnaire Stephen J. Heishman, Rebecca Evans, Edward G. Singleton, Drug and Alcohol Dependence Cannabis UseSubstance AbuseSubstance UseHealth SciencesPsychiatry	2009	202
Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration David M. Schwope, Erin L Karschner, David A. Gorelick, Clinical Chemistry	2011	184
Effect of Fluoxetine on Alcohol Consumption in Male Alcoholics David A. Gorelick, Alfonso Paredes Alcoholism Clinical and Experimental Research	1992	174
The future of endocannabinoid-oriented clinical research after CB1 antagonists Bernard Le Foll, David A. Gorelick, Steven R. Goldberg Psychopharmacology Cannabis UseCb1 AntagonistsFunctional SelectivityPharmacologyMedicine	2009	169
Imaging Brain Mu-Opioid Receptors in Abstinent Cocaine Users: Time Course and Relation to Cocaine Craving David A. Gorelick, Yu Kyeong Kim, Badreddine Bencherif, Biological Psychiatry Substance AbuseSubstance UseBehavioral NeuroscienceAddictionBrain Mu-opioid Receptors	2005	166
The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule Eric T. Moolchan, Aleksandras Radzius, David H. Epstein, Addictive Behaviors Tobacco ControlSubstance AbuseDiagnostic Interview ScheduleSubstance UsePsychiatry	2002	166
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users Marilyn A. Huestis, Susan J. Boyd, Stephen J. Heishman, Psychopharmacology Cannabis UseSubstance AbuseMale Cannabis UsersPsychoactive DrugHealth Sciences	2007	165

Page 1